INTRODUCTION
BREAST cancer is currently the most common cancer affecting women worldwide [1]. In European women, it is the leading cause of cancer death, causing one in six of all deaths from cancers [2].In the U.S., a woman has a 12.15% (about one in eight) risk of developing breast cancer during her lifetime[3].
Mammography is one of the most reliable and effective methods for detecting breast cancer at it early stages [4]. In developed countries, population-based mammography screening programs have been implemented [1]. Women are encouraged to participatein regular breast examinations through mammography. In the U.S., annual mammographic screening is recommended for women at normal risk, beginning at age 40 [5]. In the U.K., women aged between
…show more content…
First, for the approaches based on the shape/morphology of individual microcalcifications [7], [10], informative features cannot be attained when microcalcifications are very small (occupying only a few pixels) so that it seems meaningless to analyze the shape/morphological properties of such small objects. Second, microcalcifications may have very low contrast with respect to the surrounding tissue especially when microcalcifications form within dense tissue which has high and homogeneous intensity. As such, the lack of useful texture information within the background region affects the capability of the approaches based on the intensity variations and texture features [8], [27]. In addition, for the approaches describing the spatial distribution of microcalcifications within a cluster, the global
Masson devotes a more emotional appeal throughout the article, rather than offering confirmation to display that mammograms are not beneficial. She expresses reflection to show the reader her perspective and even contradicts herself in one aspect stating “If I should happen to discover a lump in my breast, I’ll have it evaluated. I’m not opposed to having a diagnostic mammogram” (Masson, 2010). This statement shows weakness within her argument and recognizes that there is potential in mammogram screening. Although relying on mammography is not the only primary diagnostic tool, it can however assist in the initial diagnostic process.
According to breastcancer.org, Breast Cancer is the most common cancer among women worldwide and the second most common cancer overall. In 2016, an estimated 247,000 cases of invasive breast cancer will be diagnosed in the U.S. alone. So no matter who you are or where you live, understanding breast cancer is very important. But the most important thing to know is that a diagnosis is NOT a death sentence, it can be treated.
Mammography saves lives, and it 's important to know that women know that they have a certain age to start before it 's too late. Mammography guidelines are the best tool available to screen for breast cancer, and It has helped many women in this world and it has also reduced the breast cancer death rate in the United States by 30 percent. And that all
Over the past decade breast cancer has become one of the most predominant diseases in the United States. Breast cancer starts out as a malignant tumor in the tissues of the breast which is formed from the uncontrolled growth of abnormal breast cells. Breast cancer is the most common cancer in women, but it can also appear in men. (Stephan, 2010)
Breast cancer is the most diagnosed cancer among women. Despite the many technological advances that have been made to detect breast cancer at earlier stages, it continues to kill more women than any other cancer. Breast cancer affects all women, but the mortality rates from it are significantly higher in Black women than any other group (Hunt, Whitman, & Hurlbert, 2013). These rates are especially concerning when considering that White women are diagnosed at much higher rates.
It is estimated that 40,030 deaths from breast cancer (39,620 women, 410 men) are will occur in 2013. Breast cancer is second only to lung cancer as the leading cause of cancer deaths in women. Breast cancer death rates have been decreasing steadily since 1989, rates decreased by 3.0% per year in women younger than 50 and by 2.0% per year in women 50 and older between 2005 and 2009. This decline is attributed to prevention, early detection, improved healthcare services and reduced use of MHT.
Over the past two decades, mammography has become the central tool used to detect cancerous regions within the breast. This evolution has been enabled by advancements in the technology itself and its implementation into healthcare regulations of numerous countries around the world (Pisano et al., 2004). In its beginning stages, breast cancer is a relatively treatable disease, and increased awareness for both mammograms and self-breast examinations have led to earlier diagnoses. Studies suggest that increases in mammography screenings have been one of the main reasons that breast
Generally speaking, throughout the United States, Cancer is a public health concern that has a significant impact amongst both men and women. At the same time, Breast Cancer indicates development of a tumor from cells in the breast known as a malignant tumor. Breast Cancer can begin at two different points, either the cells of the lobules, that are milk-producing glands, or the ducts, a channel draining milk from the lobule to the nipple (“What is Breast Cancer,” 2016). Specifically speaking about Breast Cancer among women, according to the Center for Disease Control and Prevention (2016), it is the most common cancer, regardless of ethnicity or race. Under those
Breast cancer is the second leading cause of death in women in the United States. A mammogram, is a simple test done with x-ray, to screen women for abnormalities of the breast. Over the past six years, the guidelines put out by various healthcare organizations have changed multiple times on when women should begin screening mammograms. Based on statistical data collected by the Kaiser Family Foundation (KFF), 20 percent of women go without a screening mammogram for their own various reasons, of which may be lack of insurance, lack of time or lack of knowledge as to when they should be getting a screening mammogram done due to the recent changes in recommendations. The utilization of annual screening mammograms beginning at age 40 will continue to help reduce the incidence rate of women with breast cancer, or catch it early enough so that treatment can be sought.
Breast cancer is the most common cancer among women (Macacu, Autier, Boniol & Boyle, 2015). In 2013 in the United State, 40,030 female have lost their life to breast cancer (Bryan, Westmaas, Alcaraz & Jemal, 2014). When women reach the appropriate age for mammogram screening, it should be recommended by their nurse practitioner. Mammogram screening is used to detect early breast cancer and it is the most reliable test that practitioner used to detect breast cancer (Randel, 2016).
The Author reports that the new recommended age for mammograms, by the United States Preventative Services Task Force, has changed from 50 to 40 to reduce the harm from over screening and overtreatment. It also reports that self-breast examinations are no longer recommended on a regular basis. This recommendation comes from evidence that there are no major benefits of early screenings and that only “one cancer death is prevented for every 1,904 women” screened, age 40 to 49. Conversely, there is evidence that frequent early screenings can lead to overtreatment
Three-quarters of all breast cancer patients are not in any of the groups considered at increased risk for breast cancer, indicating that not all risk factors are understood. As a result, doctors recommend that every woman should familiarize herself with the techniques for monthly breast self-examination. X-ray examination of the breasts, a technique called mammography, can detect tumors before they are large enough to be felt and increase the odds for successful treatment. The American Cancer Society recommends that women over age 40
Breast cancer is the most common type of cancer in women, it accounts for one of every three diagnoses in the United States. Breast cancers are malignancies, life threatening tumors that develops in one or both breasts.
Breast cancer is cancer that forms in the tissues of the breast, usually in the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk) (Bradley and Roberts 2002). Breast cancer occurs in both men and women, although breast cancer in men is considered rare (Vona-Davis and Rose 2009) The exact causes of breast cancer are unknown; however, research has shown that women with certain risk factors are more likely than others to develop breast cancer. According to(Jack and Holt 2008)), there are about 1.38 million new cases and 458 000 deaths from breast cancer each year. Breast cancer is by far the most common cancer in women worldwide, both in the developed and developing countries. The majority of deaths (269 000) occur in low- and middle-income countries, where most women with breast
Breast cancer accounts for one third of all new cancer diagnoses in the United States (Cauley, et al., 2007). The first sign in the process of this disease is a lump that forms around the breasts. For this reason, it is necessary to get the yearly mammograms once a woman reaches a certain age. Also, monthly self-examinations can aid in finding breast cancer early. If this condition is found early enough, chances of survival are abundant. Most women who get breast cancer are older than 50 with 86% of the deaths occurring in this age group (Cauley, et al., 2007). Postmenopausal women have a higher risk for breast cancer, because the risk increases when levels of endogenous estradiol rise (Cauley, et al., 2007). Breast cancer is the most common cancer that occurs in women. This epidemic has a higher incidence rate among white women than in African American women, but African American women have a higher mortality rate (Breast Cancer Risk Factors, 2010). White women are more apt to develop this disease than any other ethnicity. However, in women under 45, breast cancer is more common in African American women (Breast Cancer Risk Factors, 2010).